Literature DB >> 8931986

Cyclosporin A induces transcription of transforming growth factor beta in a cultured murine proximal tubular cell line.

G Wolf1, G Zahner, F N Ziyadeh, R A Stahl.   

Abstract

One pathological feature of chronic cyclosporin A (Cs-A) nephrotoxicity is striped interstitial fibrosis, the pathogenesis of which is not completely understood. We have previously reported that Cs-A directly stimulates the synthesis of various collagens in a cultured murine proximal tubular cell line (MCT cells). In addition, we have recently observed that Cs-A stimulates the synthesis of transforming growth factor beta (TGF-beta) in MCT cells. To this end, we investigated whether Cs-A directly stimulates transcription of TGF-beta in this cell line. A single dose of 2,000 ng/ml Cs-A stimulates the expression of TGF-beta1 transcripts in MCT cells. This stimulation is abrogated in the presence of 150 and 250 ng/ml actinomycin D without significantly influencing basal mRNA expression, suggesting that the increase in mRNA is due to stimulated transcriptional activity. Furthermore, nuclear runoff experiments demonstrate that Cs-A directly stimulates the transcriptional activity of the TGF-beta1 gene in MCT cells. The results of transient transfection of reporter gene constructs containing regulatory elements of the murine TGF-beta1 promoter into MCT cells and subsequent treatment with Cs-A further suggest direct effects of Cs-A on TGF-beta1 gene transcription. This is the first report demonstrating Cs-A-mediated TGF-beta1 gene transcription in renal cells. Considering the well-known profibrogenic effects of TGF-beta, our results suggest a novel mechanism of Cs-A nephrotoxicity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8931986

Source DB:  PubMed          Journal:  Exp Nephrol        ISSN: 1018-7782


  2 in total

1.  Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs.

Authors:  J G Lunz; S Contrucci; K Ruppert; N Murase; J J Fung; T E Starzl; A J Demetris
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

2.  Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro.

Authors:  Lu Xie; Brian K Law; Anna M Chytil; Kimberly A Brown; Mary E Aakre; Harold L Moses
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.